The First Drug Designed to Actually Heal Broken Bones with Sahar Meiron

In this episode of the Healthcare Growth Cycle Podcast, Sahar Meiron shares his entrepreneurial journey in the biotech industry, focusing on his company OrthoTreat, which aims to redefine orthopedic medicine. He discusses the challenges of funding, the importance of building a strong team, and the strategies for customer acquisition and market research. Sahar also delves into the complexities of clinical trials and regulatory pathways, emphasizing the significance of value-based care in the healthcare landscape. Throughout the conversation, he highlights the importance of relationships and the human factor in driving innovation and success in the biotech field. Chapters 00:00 Introduction to Sahar Meiron and His Journey 05:13 Funding Challenges in Biotech 09:06 Core Product and Technology Overview 14:21 Customer Acquisition and Market Strategy 15:29 Clinical Trials and Regulatory Pathways 16:30 Team Building and Company Culture 19:12 Operational Components of a Biotech Startup 21:02 Market Research and Data Utilization 22:26 Understanding Customer Dynamics in Biotech 26:10 Value-Based Care and Product Market Fit 29:39 Challenges and Rewards of Scaling a Biotech Company Sahar's LinkedIn:

You can listen to The First Drug Designed to Actually Heal Broken Bones with Sahar Meiron online on Radio and Podcast. Open the player on this page to stream the available audio.

The First Drug Designed to Actually Heal Broken Bones with Sahar Meiron is an episode from Passion2Knowledge by Data & Impact.

This episode is 35:46 long.

This episode was published on Apr 7, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Passion2Knowledge when more episodes are available from the podcast feed.